New policy proposal charts the future of early Alzheimer’s treatment

Two people seated indoors at a table during an event or meeting, with one person in the foreground wearing a patterned shirt and vest, and another person turned slightly to the side in conversation.

Sterling Johnson, PhD, is co-author of a forthcoming Policy View in the March issue of The Lancet Neurology. The paper offers recommendations in Alzheimer’s disease treatment and prevention, with important considerations for treatments in people who are cognitively unimpaired but at risk of future symptoms.

“We discuss the scientific, clinical and policy implications of moving disease-modifying therapies earlier in the disease continuum,” Dr. Johnson said. “Our recommendations are framed for the U.S. context, with relevance internationally, and we hope readers find it timely and useful.”

Read the full article on the Wisconsin Alzheimer's Institute (WAI) website